İÇLİ, F. Et Al. 2005. Addition of 2 cycles of EP (Etoposide Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years.. Journal of Clinical Oncology, ASCO Annual Meeting Proceedings .

İÇLİ, F., AKBULUT, H., DİNÇOL, D., ONUR, H., DEMİRKAZIK, A., ÇAM, R., ... ÇAY ŞENLER, F.(2005). Addition of 2 cycles of EP (Etoposide Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years. . Journal of Clinical Oncology, ASCO Annual Meeting Proceedings

İÇLİ, FİKRİ Et Al. "Addition of 2 cycles of EP (Etoposide Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years.," Journal of Clinical Oncology, ASCO Annual Meeting Proceedings, 2005

İÇLİ, FİKRİ Et Al. "Addition of 2 cycles of EP (Etoposide Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years.." Journal of Clinical Oncology, ASCO Annual Meeting Proceedings , 2005

İÇLİ, F. Et Al. (2005) . "Addition of 2 cycles of EP (Etoposide Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years.." Journal of Clinical Oncology, ASCO Annual Meeting Proceedings .

@conferencepaper{conferencepaper, author={FİKRİ İÇLİ Et Al. }, title={Addition of 2 cycles of EP (Etoposide Cisplatin) to the 4 cycles of adjuvant AC (doxorubicin cyclophosphamide) improves the survival in node positive patients with breast cancer after 10 years.}, congress name={Journal of Clinical Oncology, ASCO Annual Meeting Proceedings}, city={}, country={}, year={2005}}